Participation of adrenergic and noradrenergic neurones in central connections of arterial baroreceptor reflexes in the rat

Circulation Research
J P ChalmersJ L Reid

Abstract

We examined activities of tyrosine hydroxylase (TH) and phenylethanolamine-N-methyl transferase (PNMT) and concentrations of norepinephrine (NE) in seven brain regions and the spinal cord of Wistar rats with elevated blood pressures 1 week and 4 weeks after denervation of carotid and aortic baroreceptors, and compared them to values in sham-operated control rats. TH activity was increased in the solitary tract nucleus (to 188% of control), parahypoglossal nucleus (to 254%), locus ceruleus (to 191%), and posterior hypothalamus (to 225%) at 1 week but not at 4 weeks after denervation. Similarly, NE concentrations were significantly altered in a number of brain regions at 1 week but not at 4 weeks after denervation. The only change in NE concentration at 4 weeks was in spinal cord where the level was reduced to 80% of control in the denervated rats. In contrast, the only change in PNMT activity 1 week after denervation was in posterior hypothalamus (to 59% of control), whereas at 4 weeks there was in increase in the spinal cord (to 159%) and a decrease in both the anterior and posterior hypothalamus (to 59% and 64% of control, respectively). The experiments suggest that increased activity of noradrenergic neurones in the brain may...Continue Reading

References

Feb 5, 1982·European Journal of Pharmacology·Y YamoriW Lovenberg
Jan 2, 1985·European Journal of Pharmacology·P DominiakH Grobecker
Feb 1, 1985·Journal of the Autonomic Nervous System·P R Howe
Jun 15, 1991·Journal of the Autonomic Nervous System·V A Maisky, N Z Doroshenko
Jan 1, 1988·Progress in Neuro-psychopharmacology & Biological Psychiatry·I N Mefford
Aug 1, 1996·Progress in Neurobiology·Y MisuH Okamura
Jan 1, 1985·General Pharmacology·C A Taira, M A Enero
Jan 1, 1990·General Pharmacology·C A Taira, M A Enero
Mar 1, 1994·General Pharmacology·C A Taira, M A Enero
May 29, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Javier A W OpezzoC A Taira
Sep 1, 1981·Clinical and Experimental Pharmacology & Physiology·J P ChalmersY Wallman
May 1, 1982·Clinical and Experimental Pharmacology & Physiology·M J Morris, E A Woodcock
May 1, 1983·Clinical and Experimental Pharmacology & Physiology·M J Morris, E A Woodcock
Jan 1, 1981·Clinical and Experimental Hypertension : CHE·J P ChalmersJ B Furness
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·J P ChalmersP R Howe
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·M T Velasquez, N Alexander
Aug 1, 1980·Circulation Research·D L Eckberg
Dec 24, 2002·Avian Diseases·R B Williams
Jan 1, 1986·Basic Research in Cardiology·P DominiakH Grobecker
Mar 29, 2001·Clinical and Experimental Hypertension : CHE·G Cat GenovaL Chiandussi

Citations

Jan 1, 1978·Acta Physiologica Scandinavica·J V Jones, M Hallbäck
Jan 1, 1977·Progress in Brain Research·D H VersteegW De Jong
Feb 1, 1975·Life Sciences·D P HenryR H Williams
Apr 1, 1969·Circulation Research·V DeQuattroN Alexander
Apr 1, 1971·Physiological Reviews·P I Korner

Related Concepts

Cholinergic Fibers
Adrenergic Fibers
Diastolic Blood Pressure
Brain
Pressoreceptors
Norepinephrine, (+, -)-Isomer
Pnmt
Denervation
Methyltransferase
Rat-Bite Fever

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Synapse Loss as Therapeutic Target in MS

As we age, the number of synapses present in the human brain starts to decline, but in neurodegenerative diseases this occurs at an accelerated rate. In MS, it has been shown that there is a reduction in synaptic density, which presents a potential target for treatment. Here is the latest research on synapse loss as a therapeutic target in MS.

Artificial Intelligence in Cardiac Imaging

Artificial intelligence (ai) techniques are increasingly applied to cardiovascular (cv) medicine in cardiac imaging analysis. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

Social Learning

Social learning involves learning new behaviors through observation, imitation and modeling. Follow this feed to stay up to date on the latest research.

Cell Atlas of the Human Eye

Constructing a cell atlas of the human eye will require transcriptomic and histologic analysis over the lifespan. This understanding will aid in the study of development and disease. Find the latest research pertaining to the Cell Atlas of the Human Eye here.

Single Cell Chromatin Profiling

Techniques like ATAC-seq and CUT&Tag have the potential to allow single cell profiling of chromatin accessibility, histones, and TFs. This will provide novel insight into cellular heterogeneity and cell states. Discover the latest research on single cell chromatin profiling here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells.